163 related articles for article (PubMed ID: 11293886)
1. [Prevalence of antiphospholipid syndrome in patients with systemic lupus erythematosus at the University Hospital of Puerto Rico].
Carmona Cruz II; González-Parés E
P R Health Sci J; 2000 Dec; 19(4):341-4. PubMed ID: 11293886
[TBL] [Abstract][Full Text] [Related]
2. The value of IgA antiphospholipid testing for diagnosis of antiphospholipid (Hughes) syndrome in systemic lupus erythematosus.
Bertolaccini ML; Atsumi T; Escudero Contreras A; Khamashta MA; Hughes GR
J Rheumatol; 2001 Dec; 28(12):2637-43. PubMed ID: 11764209
[TBL] [Abstract][Full Text] [Related]
3. Determinants of risk for venous and arterial thrombosis in primary antiphospholipid syndrome and in antiphospholipid syndrome with systemic lupus erythematosus.
Danowski A; de Azevedo MN; de Souza Papi JA; Petri M
J Rheumatol; 2009 Jun; 36(6):1195-9. PubMed ID: 19447935
[TBL] [Abstract][Full Text] [Related]
4. Anti-beta2-glycoprotein I: prevalence, clinical correlations, and importance of persistent positivity in patients with antiphospholipid syndrome and systemic lupus erythematosus.
Danowski A; Kickler TS; Petri M
J Rheumatol; 2006 Sep; 33(9):1775-9. PubMed ID: 16960938
[TBL] [Abstract][Full Text] [Related]
5. Antiphospholipid syndrome nephropathy in patients with systemic lupus erythematosus and antiphospholipid antibodies: prevalence, clinical associations, and long-term outcome.
Tektonidou MG; Sotsiou F; Nakopoulou L; Vlachoyiannopoulos PG; Moutsopoulos HM
Arthritis Rheum; 2004 Aug; 50(8):2569-79. PubMed ID: 15334471
[TBL] [Abstract][Full Text] [Related]
6. IgG anti-beta(2) glycoprotein I antibodies in Malaysian patients with antiphospholipid syndrome and systemic lupus erythematosus: prevalence and clinical correlations.
Ong SG; Cheng HM; Soon SC; Goh E; Chow SK; Yeap SS
Clin Rheumatol; 2002 Sep; 21(5):382-5. PubMed ID: 12223986
[TBL] [Abstract][Full Text] [Related]
7. Mortality study in Puerto Ricans with systemic lupus erythematosus.
Rodríguez VE; González-Parés EN
P R Health Sci J; 2000 Dec; 19(4):335-9. PubMed ID: 11293885
[TBL] [Abstract][Full Text] [Related]
8. Early clinical manifestations, disease activity and damage of systemic lupus erythematosus among two distinct US Hispanic subpopulations.
Vilá LM; Alarcón GS; McGwin G; Friedman AW; Baethge BA; Bastian HM; Fessler BJ; Reveille JD;
Rheumatology (Oxford); 2004 Mar; 43(3):358-63. PubMed ID: 14623949
[TBL] [Abstract][Full Text] [Related]
9. Antiphospholipid antibodies and incidence of venous thrombosis in a cohort of patients with systemic lupus erythematosus.
Somers E; Magder LS; Petri M
J Rheumatol; 2002 Dec; 29(12):2531-6. PubMed ID: 12465147
[TBL] [Abstract][Full Text] [Related]
10. Neuropsychiatric manifestations and their clinical associations in southern Chinese patients with systemic lupus erythematosus.
Mok CC; Lau CS; Wong RW
J Rheumatol; 2001 Apr; 28(4):766-71. PubMed ID: 11327248
[TBL] [Abstract][Full Text] [Related]
11. The prevalence of antiphospholipid antibody syndrome among systemic lupus erythematosus patients.
McMahon MA; Keogan M; O'Connell P; Kearns G
Ir Med J; 2006; 99(10):296-8. PubMed ID: 17274170
[TBL] [Abstract][Full Text] [Related]
12. Prevalence and clinicopathologic findings of antiphospholipid syndrome nephropathy in Thai systemic lupus erythematosus patients who underwent renal biopsies.
Cheunsuchon B; Rungkaew P; Chawanasuntorapoj R; Pattaragarn A; Parichatikanond P
Nephrology (Carlton); 2007 Oct; 12(5):474-80. PubMed ID: 17803471
[TBL] [Abstract][Full Text] [Related]
13. Anti-heparin platelet factor 4 antibodies in systemic lupus erythematosus are associated with IgM antiphospholipid antibodies and the antiphospholipid syndrome.
Alpert D; Mandl LA; Erkan D; Yin W; Peerschke EI; Salmon JE
Ann Rheum Dis; 2008 Mar; 67(3):395-401. PubMed ID: 17644539
[TBL] [Abstract][Full Text] [Related]
14. [Cardiovascular risk factors in systemic lupus erythematosus and in antiphospholipid syndrome].
Sarzi-Puttini P; Atzeni F; Carrabba M
Minerva Med; 2003 Apr; 94(2):63-70. PubMed ID: 12858154
[TBL] [Abstract][Full Text] [Related]
15. Antiphospholipid syndrome.
Gezer S
Dis Mon; 2003 Dec; 49(12):696-741. PubMed ID: 14679358
[TBL] [Abstract][Full Text] [Related]
16. Gout in systemic lupus erythematosus and overlap syndrome - a hospital-based study.
Ho HH; Lin JL; Wu YJ; Yu KH; Chen JY; Luo SF
Clin Rheumatol; 2003 Oct; 22(4-5):295-8. PubMed ID: 14579159
[TBL] [Abstract][Full Text] [Related]
17. Longitudinal study of antinuclear and anticardiolipin antibodies in pregnant women with systemic lupus erythematosus and antiphospholipid syndrome.
Salazar-Páramo M; Jara LJ; Ramos A; Barile L; Machado G; García-De La Torre I
Rheumatol Int; 2002 Aug; 22(4):142-7. PubMed ID: 12172952
[TBL] [Abstract][Full Text] [Related]
18. Clinical manifestations and vascular events in patients with lupus erythematosus anticardiolipin antibodies and raynaud's phenomenon.
Rodriguez VE; Gonzalez-Pares EN; Rivera C
P R Health Sci J; 2006 Dec; 25(4):307-13. PubMed ID: 17550096
[TBL] [Abstract][Full Text] [Related]
19. High prevalence of anti-prothrombin antibody in patients with deep vein thrombosis.
Ishikura K; Wada H; Kamikura Y; Hattori K; Fukuzawa T; Yamada N; Nakamura M; Nobori T; Nakano T
Am J Hematol; 2004 Aug; 76(4):338-42. PubMed ID: 15282665
[TBL] [Abstract][Full Text] [Related]
20. [Anticardiolipin antibodies in patients with systemic lupus erythematosus].
Petrović R; Petrović M; Novicić-Sasić D; Damjanov N
Srp Arh Celok Lek; 1994; 122 Suppl 1():98-100. PubMed ID: 18173204
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
